回复：“维生素 D 补充剂在流感和 COVID-19 感染中的作用。评论：维生素 D 补充剂可降低流感和 COVID-19 感染及死亡风险的证据 2020，（4），988”。
Reply: "Vitamin D Supplementation in Influenza and COVID-19 Infections. Comment on: Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths 2020, (4), 988".
机构信息
Sunlight, Nutrition, and Health Research Center, P.O. Box 641603, San Francisco, CA 94164-1603, USA.
GrassrootsHealth, Encinitas, CA 95101, USA.
出版信息
Nutrients. 2020 Jun 1;12(6):1620. doi: 10.3390/nu12061620.
Abstract
We thank Dr [...].
摘要
我们感谢 [...] 博士。
相似文献
1
Reply: "Vitamin D Supplementation in Influenza and COVID-19 Infections. Comment on: Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths 2020, (4), 988".回复：“维生素 D 补充剂在流感和 COVID-19 感染中的作用。评论：维生素 D 补充剂可降低流感和 COVID-19 感染及死亡风险的证据 2020，（4），988”。
Nutrients. 2020 Jun 1;12(6):1620. doi: 10.3390/nu12061620.
2
Vitamin D Supplementation in Influenza and COVID-19 Infections Comment on: "Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths" 2020, (4), 988.维生素 D 补充剂在流感和 COVID-19 感染中的作用 评论：“维生素 D 补充剂可降低流感和 COVID-19 感染及死亡风险的证据”，2020 年，（4），988.
Nutrients. 2020 Jun 1;12(6):1626. doi: 10.3390/nu12061626.
3
Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.证据表明，维生素 D 补充剂可能降低流感和 COVID-19 感染及死亡风险。
Nutrients. 2020 Apr 2;12(4):988. doi: 10.3390/nu12040988.
4
Vitamin D Insufficiency May Account for Almost Nine of Ten COVID-19 Deaths: Time to Act. Comment on: "Vitamin D Deficiency and Outcome of COVID-19 Patients". 2020, , 2757.维生素 D 不足可能导致近十分之九的 COVID-19 死亡：是采取行动的时候了。评论：“维生素 D 缺乏与 COVID-19 患者结局”。2020 年，2757 年。
Nutrients. 2020 Nov 27;12(12):3642. doi: 10.3390/nu12123642.
5
Reply to: "Vitamin D Insufficiency May Account for Almost Nine of Ten COVID-19 Deaths: Time to Act. Comment on: Vitamin D Deficiency and Outcome of COVID-19 Patients. 2020, , 2757".回复：“维生素 D 不足可能导致近十分之九的 COVID-19 死亡：是采取行动的时候了。评论：维生素 D 缺乏和 COVID-19 患者的结果。2020 年，，2757”。
Nutrients. 2020 Nov 27;12(12):3643. doi: 10.3390/nu12123643.
6
Letter to the Editor: Is Vitamin D One of the Key Elements in COVID-19 Days?致编辑的信：维生素D是新冠疫情期间的关键要素之一吗？
J Nutr Health Aging. 2020;24(9):1038-1039. doi: 10.1007/s12603-020-1413-5.
7
Vitamin D status as a predictor of Covid-19 risk in Black, Asian and other ethnic minority groups in the UK.维生素D状态作为英国黑人、亚洲人和其他少数族裔群体感染新冠病毒风险的预测指标
Diabetes Metab Res Rev. 2020 Nov;36(8):e3375. doi: 10.1002/dmrr.3375. Epub 2020 Jul 31.
8
Role of vitamin D in preventing of COVID-19 infection, progression and severity.维生素 D 在预防 COVID-19 感染、进展和严重程度中的作用。
J Infect Public Health. 2020 Oct;13(10):1373-1380. doi: 10.1016/j.jiph.2020.06.021. Epub 2020 Jun 20.
9
Exploring links between vitamin D deficiency and COVID-19.探讨维生素 D 缺乏与 COVID-19 之间的联系。
PLoS Pathog. 2020 Sep 18;16(9):e1008874. doi: 10.1371/journal.ppat.1008874. eCollection 2020 Sep.
10
Vitamin D deficiency and the COVID-19 pandemic.维生素 D 缺乏与 COVID-19 大流行。
J Glob Antimicrob Resist. 2020 Sep;22:133-134. doi: 10.1016/j.jgar.2020.05.006. Epub 2020 May 29.
引用本文的文献
1
Analysis of vitamin D nutritional status and disease risk factors in patients with subacute thyroiditis.亚急性甲状腺炎患者维生素D营养状况及疾病危险因素分析
Ther Adv Endocrinol Metab. 2025 Apr 4;16:20420188251321600. doi: 10.1177/20420188251321600. eCollection 2025.
2
Vitamin D and COVID-19: comparative analysis with other respiratory infections and impact of comorbidities.维生素D与2019冠状病毒病：与其他呼吸道感染的比较分析及合并症的影响
Germs. 2024 Sep 30;14(3):232-245. doi: 10.18683/germs.2024.1435. eCollection 2024 Sep.
3
The association between adherence to unhealthy plant-based diet and risk of COVID-19: a cross-sectional study.不健康植物性饮食与 COVID-19 风险之间的关联：一项横断面研究。
BMC Infect Dis. 2024 Nov 5;24(1):1245. doi: 10.1186/s12879-024-10115-7.
4
Public Health Risk from Influenza Viruses: A Scientometric Analysis of Influenza Research.流感病毒带来的公共卫生风险：流感研究的科学计量分析
Iran J Public Health. 2024 Aug;53(8):1826-1836. doi: 10.18502/ijph.v53i8.16288.
5
Serum 25-hydroxyvitamin D levels and health outcomes of hospitalization owing to COVID-19: a retrospective cross-sectional study.血清 25-羟维生素 D 水平与因 COVID-19 住院的健康结局：一项回顾性横断面研究。
J Int Med Res. 2024 Aug;52(8):3000605241271770. doi: 10.1177/03000605241271770.
6
Severe COVID-19 infection: An institutional review and literature overview.严重 COVID-19 感染：机构审查和文献综述。
PLoS One. 2024 Aug 20;19(8):e0304960. doi: 10.1371/journal.pone.0304960. eCollection 2024.
7
Comparing vitamin D receptor gene polymorphisms in rs11568820, rs7970314, rs4334089 between COVID-19 patients with mild and severe symptoms: a case control study.比较轻度和重度症状COVID-19患者中rs11568820、rs7970314、rs4334089维生素D受体基因多态性：一项病例对照研究。
Sci Rep. 2024 May 3;14(1):10170. doi: 10.1038/s41598-024-57424-0.
8
The role of vitamin D in outcomes of critical care in COVID-19 patients: evidence from an umbrella meta-analysis of interventional and observational studies.维生素 D 在 COVID-19 患者重症监护结局中的作用：来自干预性和观察性研究的伞状荟萃分析证据。
Public Health Nutr. 2024 Apr 24;27(1):e127. doi: 10.1017/S1368980024000934.
9
The role of micronutrients in the management of COIVD-19 and optimizing vaccine efficacy.微量营养素在新冠病毒疾病（COVID-19）管理及优化疫苗效力中的作用。
Hum Nutr Metab. 2022 Mar;27:200141. doi: 10.1016/j.hnm.2022.200141. Epub 2022 Jan 25.
10
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID.精准营养以重置长期新冠病毒感染中病毒诱导的人类代谢重编程和失调（HMRD）。
NPJ Sci Food. 2024 Mar 30;8(1):19. doi: 10.1038/s41538-024-00261-2.
本文引用的文献
1
COVID-19 antibody seroprevalence in Santa Clara County, California.加利福尼亚州圣克拉拉县的新冠病毒抗体血清流行率。
Int J Epidemiol. 2021 May 17;50(2):410-419. doi: 10.1093/ije/dyab010.
2
COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis.COVID-19的临床特征及性别特异性死亡风险：系统评价与荟萃分析
Front Med (Lausanne). 2020 Jul 21;7:459. doi: 10.3389/fmed.2020.00459. eCollection 2020.
3
Vitamin D Supplementation in Influenza and COVID-19 Infections Comment on: "Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths" 2020, (4), 988.维生素 D 补充剂在流感和 COVID-19 感染中的作用 评论：“维生素 D 补充剂可降低流感和 COVID-19 感染及死亡风险的证据”，2020 年，（4），988.
Nutrients. 2020 Jun 1;12(6):1626. doi: 10.3390/nu12061626.
4
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.2020 年 3 月 1 日至 30 日，14 个州住院的经实验室确诊的 2019 冠状病毒病患者的住院率和特征 - COVID-NET。
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.
5
Vitamins D3 and D2 have marked but different global effects on gene expression in a rat oligodendrocyte precursor cell line.维生素 D3 和 D2 对大鼠少突胶质前体细胞系的基因表达具有显著但不同的全球影响。
Mol Med. 2020 Apr 9;26(1):32. doi: 10.1186/s10020-020-00153-7.
6
Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.证据表明，维生素 D 补充剂可能降低流感和 COVID-19 感染及死亡风险。
Nutrients. 2020 Apr 2;12(4):988. doi: 10.3390/nu12040988.
7
Serum Vitamin D Concentration ≥75 nmol/L Is Related to Decreased Cardiometabolic and Inflammatory Biomarkers, Metabolic Syndrome, and Diabetes; and Increased Cardiorespiratory Fitness in US Adults.血清维生素 D 浓度≥75nmol/L 与美国成年人的心血管代谢和炎症生物标志物降低、代谢综合征和糖尿病减少以及心肺功能提高有关。
Nutrients. 2020 Mar 10;12(3):730. doi: 10.3390/nu12030730.
8
The effect of vitamin D supplementation on hemoglobin concentration: a systematic review and meta-analysis.维生素 D 补充对血红蛋白浓度的影响：系统评价和荟萃分析。
Nutr J. 2020 Feb 3;19(1):11. doi: 10.1186/s12937-020-0526-3.
9
Early High-Dose Vitamin D for Critically Ill, Vitamin D-Deficient Patients.危重症、维生素 D 缺乏患者的早期高剂量维生素 D 治疗。
N Engl J Med. 2019 Dec 26;381(26):2529-2540. doi: 10.1056/NEJMoa1911124. Epub 2019 Dec 11.
10
Why Secondary Analyses in Vitamin D Clinical Trials Are Important and How to Improve Vitamin D Clinical Trial Outcome Analyses-A Comment on "Extra-Skeletal Effects of Vitamin D, 2019, , 1460".为什么维生素 D 临床试验中的二次分析很重要，以及如何改进维生素 D 临床试验结果分析——对“维生素 D 的骨骼外作用，2019 年，，1460”的评论
Nutrients. 2019 Sep 11;11(9):2182. doi: 10.3390/nu11092182.
Zotero 插件